Cancer Cell
Volume 34, Issue 5, 12 November 2018, Pages 775-791.e3
ArticlePEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
PEGylated Interleukin 10
IL-10
pegilodecakin
AM0010
clinical trial
CD8+ T cell
clonality
clonal expansion
T cell invigoration
Th1
Cited by (0)
© 2018 Elsevier Inc.